Structure Therapeutics Inc.

GPCR | NASDAQ

Price Alert Chart Builder DCF Calculator

$36.81

+$1.81 (+5.17%)

At close: Sep 21, 2026, 4:00 PM ET

$37

+$0.19 (+0.52%)

Pre-market: Sep 22, 2026, 9:18 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.12B

Enterprise Value $782.6M

Beta -1.52

Average Volume 740.15K

Shares Outstanding (Diluted) 72.65M

Shares Change YoY 25.44%

Institutional Ownership 92.10%

Exchange NASDAQ

ISIN US86366E1064

Price Performance

Price Change 1M -24.4%

Price Change 3M -19.3%

Price Change 6M -23.5%

Price Change YTD -46.0%

Price Change 1Y 50.5%

Price Change 3Y 8.3%

Price Change 5Y 41.6%

1M CAGR (ann.) -30.7%

1Y CAGR (ann.) 58.5%

5Y CAGR (ann.) N/A

All-Time CAGR 10.0%

Valuation

PE Ratio -12.15

Forward PE N/A

PEG Ratio 0.86

Forward PEG -0.42

PS Ratio N/A

Forward PS 46,618.20

PB Ratio 1.56

P/FCF Ratio -10.07

P/Adj. FCF Ratio -8.09

P/OCF Ratio -12.15

EV/Sales N/A

EV/EBIT -3.65

EV/EBITDA -3.68

EV/FCF -3.72

Earnings Yield -8.2%

FCF Yield -9.9%

Adj. FCF Yield -12.4%

Financial Health

Net Cash $1.34B

Total Debt $6.23M

Cash & Short-Term Investments $1.34B

Total Assets $1.43B

Current Ratio 20.75

Quick Ratio 20.75

Debt / Equity Ratio 0.00

Debt / EBITDA -0.03

Debt / FCF -0.03

OCF / Debt -32.92

Interest Coverage 0.00

Altman Z-Score 17.87

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -24.5%

Returns

Return on Assets -15.1%

Return on Equity -16.9%

Return on Invested Capital -18.9%

Return on Capital Employed -19.0%

Return on Tangible Assets -15.1%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -13.3%

EPS CAGR 5Y -16.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y -32.8%

FCF CAGR 5Y -45.2%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 14

EPS Growth Next 3Y 32.9%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.33

EPS Growth Est (next Q) -12.2%

Revenue Est (next Q) $50M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $90.50

Price Target Upside 145.9%

Cash Flow

Operating Cash Flow $-205.01M

Free Cash Flow $-210.41M

Adj. Free Cash Flow $-261.88M

FCF Per Share -$3.09

OCF Per Share -$3.03

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-1.22M

Operating Income $-258.07M

EBITDA $-212.44M

Net Income $-215.06M

EPS (Diluted) -$3.03

Revenue / Employee N/A

Profit / Employee $-765.34K

Employees 281